MedTrace Logo

Comparison of Preoperative Analgesics on the Efficacy of Inferior Alveolar Nerve Block.

NCT05488925 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-08-05

No results posted yet for this study

Summary

The purpose of this study is to see how preoperative oral diclofenac sodium, piroxicam, and tramadol affects inferior alveolar nerve block efficacy during root canal treatment of mandibular molars with symptomatic irreversible pulpitis.

The proposed hypothesis is that the tested drug groups will improve the efficacy of inferior alveolar nerve block in comparison to the control group.

Conditions

  • Symptomatic Irreversible Pulpitis

Interventions

DRUG

Vitamin E

Evion, 400 mg

DRUG

Diclofenac Sodium

Voltral SR100, 100 mg

DRUG

Piroxicam

Feldene, 20 mg

DRUG

Tramadol

Tramal, 50 mg

Sponsors & Collaborators

  • Farjad Zafar

    lead OTHER

Principal Investigators

  • Farjad Zafar, BDS, MSc · Assistant Professor and Head of Department of Dental Implantology.

  • Maryam Riaz, BDS · Lecturer in Department of Oral Biology.

  • Zara Khalid, BDS · House officer.

  • Tipu Sultan, BDS, MDS · Assistant Professor in Department of Periodontology.

  • Aisha Wali, BDS, MPH · Assistant Professor and Head of Department of Research and Development.

  • Talha M Siddiqui, BDS, MCPS · Professor and Chairman of Operative Dentistry and Endodontics.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2022-02-18
Completion
2022-02-18
FDA Drug
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05488925 on ClinicalTrials.gov